Showing results (471-480 of 542) with videos related to

Sort By:
Pageof 55
British Journal of Cancer|July 20, 2016
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC studySiân A Pugh, Megan Bowers, Alexandre Ball, et al.
Academic Radiology|August 13, 2013
Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphomaFernando Arias-Mendoza, Geoffrey S Payne, Kristen Zakian, et al.
Targeted Oncology|December 27, 2015
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based TherapyEric Van Cutsem, Florence Joulain, Paulo M Hoff, et al.
European Journal of Cancer (Oxford, England : 1990)|September 23, 2021
Individual patient data meta-analysis of neoadjuvant chemotherapy followed by surgery versus upfront surgery for carcinoma of the oesophagus or the gastro-oesophageal junctionMatthieu Faron, Armel Maurice Cheugoua-Zanetsie, Pierre Thirion, et al.
European Journal of Cancer (Oxford, England : 1990)|October 14, 2019
Clonal diversity of MYC amplification evaluated by fluorescent in situ hybridisation and digital droplet polymerase chain reaction in oesophagogastric cancer: Results from a prospective clinical trial screening programmeMichael Davidson, Lauren I Aronson, Julie Howard-Reeves, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2024
Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B StudySusanna Slater, Annette Bryant, Maria Aresu, et al.
Cancer Discovery|November 6, 2012
Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradationAnna Sukhanova, Andrey Gorin, Ilya G Serebriiskii, et al.
The Oncologist|November 7, 2022
SARS-CoV-2 Vaccine Immunogenicity in Patients with Gastrointestinal Cancer Receiving Systemic Anti-Cancer TherapyDavid K Lau, Maria Aresu, Timothy Planche, et al.
Blood Advances|November 15, 2023
Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experienceRohan Shotton, Rachel Broadbent, Alia Alchawaf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2022
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II TrialCatherine Thieblemont, Tycel Phillips, Herve Ghesquieres, et al.
Pageof 55